Animal Core
Animal Core
批准号:
8055144
负责人:
Stanley Perlman
金额:
$22.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-19 至 2016-06-30
关键词:
AnimalsAntibodiesBiological AssayBody Weight decreasedCell CommunicationCell Culture TechniquesClinicalCore FacilityDNADevelopmentDiseaseEducational process of instructingEngineeringEnsureFundingGrantHeadHuman ResourcesInstructionLaboratoriesMethodologyMethodsMonitorMusPathogenesisPostdoctoral FellowProteinsProtocols documentationRNAReagentRecombinantsResearch PersonnelRoleSARS coronavirusSafetySamplingServicesShippingShipsT cell responseTissue HarvestingTissuesUniversitiesVaccine TherapyViralVirusWorkbasedata sharingdesignexperiencemembernovelprogramsrecombinant virusresearch studysuccesstissue culturevaccine candidatevaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions):
The Core Laboratory will be directed by an experienced postdoctoral fellow. Dr. Jincun Zhao, under the guidance of the Core Leader, Dr. Perlman. The Core will be primarily based in a BSL3 laboratory that is equipped for tissue culture and animal work. Personnel working in the Core are experienced in virological and cell culture techniques. The Animal Core has several functions that are critical for success of this POl grant. It will propagate and titer nonrecombinant and recombinant mouse-adapted and Urbani strains of
SARS-CoV and will infect mice with these viruses. It will monitor mice for clinical disease and weight loss and will harvest tissue. The Core will prepare samples for histological and immunohistochemical analysis and will prepare RNA and protein from infected tissue. The Core will analyze mice for antibody and T cell responses. The Core will also be responsible for ensuring that protocols for working with animals and for
working under BSL3 laboratory conditions are up-to-date. While the Core will teach members of the Project methods important for analysis of mice under BSL3 conditions, it will primarily be responsible for performing most of these analyses. The Core will provide reagents and perform common assays efficiently, thereby standardizing results and enhancing synergistic interactions. Additionally, all projects will interact with the
Core, thereby facilitating interactions between members of the PPG. By providng these services, the Core will allow Program investigators to focus on issues related to SARS-CoV pathogenesis and to the development of anti-viral therapies and vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of eicosanoids in pathogenic human CoV infections
-
批准号:9764251
-
项目类别:
-
资助金额:$54.52万
-
财政年份:2016
-
负责人:Stanley Perlman
-
依托单位:
Role of eicosanoids in pathogenic human CoV infections
-
批准号:9542722
-
项目类别:
-
资助金额:$54.52万
-
财政年份:2016
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8847630
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8164278
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8264955
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8055138
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8468102
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Administrative Core
-
批准号:8055145
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8663180
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
A novel strategy for developing a SARS-CoV vaccine
-
批准号:7904591
-
项目类别:
-
资助金额:$40.33万
-
财政年份:2009
-
负责人:Stanley Perlman
-
依托单位:
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
-
批准号:7120540
-
项目类别:
-
资助金额:$144.54万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
PPG: SARS-CoV-host cell interactions and vaccine development
-
批准号:8021280
-
项目类别:
-
资助金额:$159.97万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
PPG: SARS-CoV-host cell interactions and vaccine development
-
批准号:8304203
-
项目类别:
-
资助金额:$159.58万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
PPG: SARS-CoV-host cell interactions and vaccine development
-
批准号:8881046
-
项目类别:
-
资助金额:$159.58万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
PPG: SARS-CoV-host cell interactions and vaccine development
-
批准号:9752412
-
项目类别:
-
资助金额:$125.43万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
Project 1
-
批准号:10229390
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
PPG: SARS-CoV-host cell interactions and vaccine development
-
批准号:8494515
-
项目类别:
-
资助金额:$160.57万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
Project 4
-
批准号:9209901
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
Development of Murine Model for SARS-CoV Pathogenesis
-
批准号:6825517
-
项目类别:
-
资助金额:$28.54万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
Project-004
-
批准号:10229091
-
项目类别:
-
资助金额:$18.24万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
海外基金